History
# Registration date Revision Id
2 2025-12-25, 1404/10/04 367676
1 2025-11-21, 1404/08/30 363725
Changes made to previous revision
  • Help:

    Red color represents old content. It may be empty showing addition in the new version.
    Green color represents new content. It may be empty showing deletion in the new version.

    Inline Side by side
    Added new contents, deleted old contents, contents that are not changed.
    New table contents New table contents
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    Added new contents, contents that are not changed.
    Deleted old contents, contents that are not changed.
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    New table contents New table contents
    Unchanged contents Unchanged contents
  • General information

    2025-12-01, 1404/09/10
    2026-02-20, 1404/12/01
    2026-05-31, 1405/03/10
    2026-08-23, 1405/06/01
    empty
    Given that the initial registration of the study in the IRCT system was performed after obtaining the ethics approval and prior to the final approval by the University Research Council, the study start date entered at the time of initial registration was based on the preliminary version of the research proposal. Following further review by the Research Council and the application of the approved revisions, it became necessary to update this information to ensure full consistency between the registered data in IRCT and the final approved version of the research protocol. The purpose of this update was to enhance transparency, scientific accuracy, and complete alignment between the IRCT registration and the final approved protocol as well as the actual conduct of the study. No changes have been made to the overall nature of the study, its primary objectives, or the ethical considerations of the research.
    empty
    با توجه به این‌که ثبت اولیه مطالعه در سامانه IRCT پس از اخذ کد اخلاق و پیش از ثبت نهایی در شورای پژوهشی دانشگاه انجام شده است، زمان شروع مطالعه واردشده در زمان ثبت اولیه بر اساس نسخه‌ی اولیه پروپوزال بوده و پس از بررسی‌های تکمیلی در شورای پژوهشی و اعمال اصلاحات مصوب، نیاز به به‌روزرسانی جهت تطابق کامل اطلاعات ثبت‌شده با نسخه نهایی و مصوب طرح پژوهشی ایجاد گردید. هدف از این بروزرسانی، افزایش شفافیت، دقت علمی و هم‌خوانی کامل اطلاعات سامانه IRCT با پروپوزال نهایی مصوب و اجرای واقعی مطالعه بوده و هیچ‌گونه تغییری در ماهیت کلی مطالعه، اهداف اصلی یا ملاحظات اخلاقی پژوهش ایجاد نشده است.

Protocol summary

Study aim
Evaluation of the effect of dexmedetomidine on hemodynamic stability and opioid requirement in patients undergoing pulmonary hydatid cyst surgery
Design
A controlled, parallel-group, double-blind, block-randomized, phase 3 clinical trial on 40 patients. Block randomization using block sizes of 4 and 6 generated via the SealedEnvelope website will be applied.
Settings and conduct
This study will be conducted at Ghaem Hospital, Mashhad. Patients aged 18–65 undergoing unilateral pulmonary hydatid cyst surgery will be enrolled after informed consent and randomized using block randomization (blocks of 4 and 6 via SealedEnvelope). The intervention group receives dexmedetomidine, and the control group receives normal saline. Hemodynamic parameters are recorded at predefined times. Patients, the assessor, and the statistician are blinded, while the administering anesthesiologist is unblinded for safety.
Participants/Inclusion and exclusion criteria
Age 18 to 65 years, Candidate for unilateral pulmonary hydatid cyst surgery (thoracotomy or VATS), ASA class I–II, Having informed consent to participate.
Intervention groups
Intervention group: Will receive dexmedetomidine intravenously as a 1 µg/kg loading dose over 10 minutes, followed by a 0.5 µg/kg/h infusion until the end of surgery. Control group: Similar to the intervention group, an equivalent volume of Normal Saline will be infused at the same rate.
Main outcome variables
Hemodynamic stability (blood pressure and heart rate); intraoperative opioid consumption; postoperative pain score (VAS); postoperative nausea and vomiting (PONV)

General information

Reason for update
Given that the initial registration of the study in the IRCT system was performed after obtaining the ethics approval and prior to the final approval by the University Research Council, the study start date entered at the time of initial registration was based on the preliminary version of the research proposal. Following further review by the Research Council and the application of the approved revisions, it became necessary to update this information to ensure full consistency between the registered data in IRCT and the final approved version of the research protocol. The purpose of this update was to enhance transparency, scientific accuracy, and complete alignment between the IRCT registration and the final approved protocol as well as the actual conduct of the study. No changes have been made to the overall nature of the study, its primary objectives, or the ethical considerations of the research.
Acronym
IRCT registration information
IRCT registration number: IRCT20250626066260N1
Registration date: 2025-11-21, 1404/08/30
Registration timing: prospective

Last update: 2025-12-25, 1404/10/04
Update count: 1
Registration date
2025-11-21, 1404/08/30
Registrant information
Name
vahid Nourbakhsh
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 930 259 8031
Email address
vhn041@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2026-02-20, 1404/12/01
Expected recruitment end date
2026-08-23, 1405/06/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The Effect of Dexmedetomidine on Hemodynamic Stability and Opioid Requirement in Patients Undergoing Pulmonary Hydatid Cyst Surgery
Public title
Effect of Dexmedetomidine on Hemodynamic Stability and Opioid Requirement in Pulmonary Hydatid Cyst Surgery
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Age between 18 and 65 years Candidate for unilateral pulmonary hydatid cyst surgery (via thoracotomy or VATS) Physical status ASA class I or II Written informed consent to participate in the study
Exclusion criteria:
Age
From 18 years old to 65 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Investigator
  • Outcome assessor
Sample size
Target sample size: 40
Randomization (investigator's opinion)
Randomized
Randomization description
In this study entitled “The Effect of Dexmedetomidine on Hemodynamic Stability and Opioid Requirement in Patients Undergoing Pulmonary Hydatid Cyst Surgery,” block randomization was used. A total of 10 random blocks with variable block sizes of 4 and 6 and different random sequences were generated using the website https://www.sealedenvelope.com/simple-randomiser/v1/lists . The contents of each block were placed in opaque, sealed, and sequentially numbered envelopes, and all blocks were randomly arranged. As each eligible patient was enrolled, the envelope corresponding to the current block was opened sequentially, and the patient was assigned to one of the two study arms (Dexmedetomidine group or Control group) according to the sequence inside. After completion of the first block, the next block was randomly selected, and this process continued until the last block was completed and the final patient was allocated. Consequently, patients were equally distributed between the two study arms, ensuring proper balance. The unit of randomization in this study was individual, and no stratified randomization was applied. For allocation concealment, the envelopes were prepared opaque, sealed, and sequentially numbered to prevent the investigator from knowing the intervention type prior to patient enrollment. The study was designed as a double-blind trial, in which both patients and the data analyst were blinded to group allocation, while the anesthesiologist administering the drug was aware of the allocation for safety monitoring and management of potential adverse effects.
Blinding (investigator's opinion)
Double blinded
Blinding description
Participant: After receiving full information about the study protocol and providing written informed consent, participants remain unaware of their group allocation. Both dexmedetomidine and placebo solutions are prepared in identical syringes with the same volume and appearance by an independent staff member, ensuring that patients cannot distinguish their assigned intervention. Investigator: The principal investigator does not participate in drug preparation or allocation procedures and remains blinded to group assignments throughout the data collection phase. Allocation codes are kept in sealed envelopes and will only be opened after completion of data analysis. Outcome Assessor: The assessor responsible for recording hemodynamic variables, opioid consumption, postoperative pain scores, and clinical outcomes is fully blinded to the intervention type. The assessor works solely based on patient identification codes and has no access to information about drug assignment or administration.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Research Ethics Committees of Imam Reza Hospital Educational, Research and Treatment Center- Mashhad
Street address
Ibn Sina St., Imam Reza Hospital Square, Imam Reza Educational Research and Treatment Center
City
mashhad
Province
Razavi Khorasan
Postal code
9137913316
Approval date
2025-10-27, 1404/08/05
Ethics committee reference number
IR.MUMS.IRH.REC.1404.191

Health conditions studied

1

Description of health condition studied
Pulmonary Hydatid Cyst
ICD-10 code
B67.4
ICD-10 code description
Echinococcus granulosus infection, unspecified

Primary outcomes

1

Description
Systolic and diastolic blood pressure
Timepoint
Before induction of anesthesia; after surgical incision; every fifteen minutes during surgery; in the recovery room
Method of measurement
Measurement of systolic and diastolic blood pressure using invasive and noninvasive automatic blood pressure monitor

2

Description
Heart rate
Timepoint
Before induction of anesthesia; after surgical incision; every fifteen minutes during surgery; in the recovery room
Method of measurement
Measurement of heart rate using an electrocardiographic cardiac monitor

3

Description
Total intraoperative opioid consumption
Timepoint
From the beginning of anesthesia induction until the end of the surgical procedure
Method of measurement
Calculation of the total opioid dose based on values recorded by the anesthesia team in the anesthesia record

Secondary outcomes

1

Description
Postoperative pain score measured by the Visual Analogue Scale
Timepoint
In the recovery room; two hours after surgery; four hours after surgery
Method of measurement
Measurement using a ten-centimeter Visual Analogue Scale for pain assessment

2

Description
Postoperative nausea and vomiting
Timepoint
In the recovery room; two hours after surgery; four hours after surgery
Method of measurement
Clinical observation and documentation of nausea and vomiting events by the recovery room nurse

3

Description
Sedation level assessed by the Ramsay Sedation Scale
Timepoint
In the recovery room; thirty minutes after admission to recovery
Method of measurement
Assessment using the Ramsay Sedation Scale

Intervention groups

1

Description
Intervention group: Includes patients who, after induction of anesthesia, receive dexmedetomidine initially at a dose of 1 µg/kg over 10 minutes, followed by 0.5 µg/kg/h via intravenous infusion until the end of surgery.
Category
Treatment - Drugs

2

Description
Control group: Includes patients who, under the same anesthetic conditions, receive an equivalent volume of normal saline instead of dexmedetomidine at the same infusion rate (placebo). Other anesthetic management and therapeutic interventions are the same as in the intervention group.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Ghaem hospital
Full name of responsible person
Vahid Nourbakhsh
Street address
Ahmadabad Street, Qaem Hospital
City
mashhad
Province
Razavi Khorasan
Postal code
9176699199
Phone
+98 915 834 0408
Fax
Email
vhn041@gmail.com
Web page address

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Mohsen Tafaqodi
Street address
Daneshgah Street - next to Howezeh Cinema - Qureshi Building - Research and Technology Vice-Chancellor
City
mashhad
Province
Razavi Khorasan
Postal code
9138813944
Phone
+98 51 3841 1538
Email
vcresearch@mums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Mashhad University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Vahid Nourbakhsh
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
Ahmadabad Street, Qaem Hospital
City
mashhad
Province
Razavi Khorasan
Postal code
9176699199
Phone
+98 915 834 0408
Fax
Email
vhn041@gmail.com
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Alireza Sharifian Attar
Position
Professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Ahmadabad Street, Qaem Hospital
City
mashhad
Province
Razavi Khorasan
Postal code
9176699199
Phone
009153150596
Fax
Email
sharifiana@mums.ac.ir
Web page address

Person responsible for updating data

Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Vahid Nourbakhsh
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
Ahmadabad Street, Qaem Hospital
City
mashhad
Province
Razavi Khorasan
Postal code
9176699199
Phone
+98 915 834 0408
Fax
Email
vhn041@gmail.com
Web page address

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...